Analyst
Equibles does not estimate personal net worth.
Joseph Eid has spoken on 1 earnings call and 2 other investor events across 1 company, most recently for Geron Corp on November 10, 2026. The companies whose calls Joseph Eid spoke on are classified in the Healthcare sector.
“Yeah, I mean, we had two publications in the summer and the fall showing that in the real world evidence, especially post-launch, the patients were more advanced and sicker, yet in terms of duration on therapy, they mimic in a lot of ways the IMERG study despite being a sicker population.”
“Yeah, I mean, just to complete what Harud said earlier, in my fellowship back in the 90s, the standard of care for MDS was supportive care.”
“Our medical and scientific efforts in 2025 played a critical role in increasing Gritello's share of voice within the hematology community, and we plan to continue to engage closely with the community throughout 2026.”
GERN
Biotechnology · Healthcare
